Patients with ferritin > 390 ng/mL had a higher systemic inflammation level (WBC, NEUT%), liver dysfunction (ALT, AST, TBIL, LDH, ALB), iron metabolism disorders (TF, TIBC) and partly biochemical dysfunction (BUN). Here, ALB is linked to metabolic disease.